Therapy News and Research

RSS

New treatment for Obsessive Compulsive Disorder

A new treatment for Obsessive Compulsive Disorder (OCD) pioneered at the University of Sydney is having great success by targeting the beliefs behind the obsessive behaviour rather than the behaviour itself.

15 Jun 2008

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

One of the most vexing problems in treating cancer is the propensity of tumors to develop resistance to a wide range of anticancer drugs. Over 70 percent of ovarian cancer patients, for example, have drug-resistant tumors at the time of their initial diagnosis, and virtually all patients who relapse have drug-resistant tumors.

15 Jun 2008

Cancer-detecting nanoparticles

Magnetic resonance imaging (MRI) can be a doctor's best friend for detecting a tumor in the body without resorting to surgery. MRI scans use pulses of magnetic waves and gauge the return signals to identify different types of tissue in the body, distinguishing bone from muscle, fluids from solids, and so on.

15 Jun 2008

Advanced cancer patients often unaware of life expectancies, effects of chemotherapy, according to perspective

Patients with advanced cancer often are not aware of their life expectancies or the effect that chemotherapy will have on their lives, according to a perspective published on Wednesday in the Journal of the American Medical Association, USA Today reports.

11 Jun 2008

Scaling and root planing dental treatment safe for pregnant women

Pregnant women can safely undergo essential dental treatment and receive topical and local anesthetics at 13 to 21 weeks gestation, says a study published in the June issue of The Journal of the American Dental Association.

11 Jun 2008

Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women

New analysis of a drug approved for osteoporosis prevention and treatment has provided definitive evidence that the medication is also effective as a breast cancer preventative for certain cancers.

11 Jun 2008

World experts in specialized radiation therapy to cather at University of Rochester Medical Center

Cancer survivor Jarod Finlay will share his experiences as the first patient to undergo an investigational procedure - stereotactic body radiation therapy - during a conference of world experts on the procedure this Friday and Saturday at the University of Rochester Medical Center.

11 Jun 2008

Breakthrough in understanding tumor immune therapy

Researchers from the Tubingen University, Department of Dermatology, uncovered an entirely new understanding on how the immune system may control tumor development.

11 Jun 2008

Specific immune therapy works for many people with allergies

The German Institute for Quality and Efficiency in Health Care has assessed recent evidence on allergies. It found that the once controversial immune therapy against allergy symptoms can definitely help many people with allergies.

11 Jun 2008

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Compugen Ltd. announced today the discovery of more than ten novel targets of antibody therapy for various types of solid and hematopoietic cancer.

11 Jun 2008

Without increased funding, California's dominance and public health are threatened, according to new report

The California Healthcare Institute (CHI) and PricewaterhouseCoopers (PwC) today released a report, "The National Institutes of Health: Fueling Healthcare Innovation in California," urging legislators to support increased funding for the National Institutes of Health (NIH) - the backbone of the biomedical industry in California, which employs more than 267,000 people in high wage jobs.

11 Jun 2008

Viruses genetically designed to kill cancer cells influence tumor blood-vessel growth

Viruses genetically designed to kill cancer cells offer a promising strategy for treating incurable brain tumors such as glioblastoma, but the body's natural defenses often eliminate the viruses before they can eliminate the tumor.

11 Jun 2008

Drug combo offers new approach for reversing type 1 diabetes

Promising results from a study that tested a new approach for reversing Type 1 diabetes are being presented this week at the American Diabetes Association's 68th Annual Scientific Session in San Francisco.

11 Jun 2008

Australian researchers find important piece of Alzheimer's puzzle

Queensland Brain Institute (QBI) neuroscientists at UQ have discovered a new way to reduce neuronal loss in the brain of a person with Alzheimer's disease.

11 Jun 2008

Quick responses to influenza outbreaks reduces illness and death

Influenza outbreaks were shorter and resulted in fewer cases and fewer deaths at long-term care facilities that started residents on preventive antiviral medications within five days of the first case, compared to those that started later, according to a new study in the July 1 issue of Clinical Infectious Diseases, currently available online.

11 Jun 2008

Turn up the lights and slow down dementia!

A team of Dutch scientists are suggesting that the progression of dementia can be significantly slowed down by treatments which reset the body's natural clock.

11 Jun 2008

"HiCy" drug regimen reverses multiple sclerosis symptoms in selected patients

A short-term, very-high dose regimen of the immune-suppressing drug cyclophosphamide seems to slow progression of multiple sclerosis (MS) in most of a small group of patients studied and may even restore neurological function lost to the disease, Johns Hopkins researchers report. The findings in nine people, most of whom had failed all other treatments, suggest new ways to treat a disease that tends to progress relentlessly.

10 Jun 2008

European research project to explore Alzheimer's diagnosis

VTT Technical Research Centre of Finland, GE Healthcare, a division of the General Electric Company (NYSE: GE) and a Consortium of leading research institutions across Europe announced the PredictAD project, a research collaboration aimed at developing new diagnostic procedures for patients with Alzheimer's disease.

10 Jun 2008

World leaders call for action to reduce TB deaths among HIV-positive people

For the first time ever, heads of governments, public health and business leaders, heads of UN agencies and activists came together at UN Headquarters today to confront a threat to global health that could undermine investments in life-saving drug treatment for people living with HIV.

10 Jun 2008

Nose stem cells used to treat Parkinson's

Scientists in Queensland, Australia have made a major breakthrough in research into Parkinson's disease.

9 Jun 2008

Therapy News and Research

New treatment for Obsessive Compulsive Disorder

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

Cancer-detecting nanoparticles

Advanced cancer patients often unaware of life expectancies, effects of chemotherapy, according to perspective

Scaling and root planing dental treatment safe for pregnant women

Anti-estrogen drug therapy reduces risk of invasive breast cancer in older women

World experts in specialized radiation therapy to cather at University of Rochester Medical Center

Breakthrough in understanding tumor immune therapy

Specific immune therapy works for many people with allergies

Compugen announces discovery of novel drug targets for cancer antibody therapeutics

Without increased funding, California's dominance and public health are threatened, according to new report

Viruses genetically designed to kill cancer cells influence tumor blood-vessel growth

Drug combo offers new approach for reversing type 1 diabetes

Australian researchers find important piece of Alzheimer's puzzle

Quick responses to influenza outbreaks reduces illness and death

Turn up the lights and slow down dementia!

"HiCy" drug regimen reverses multiple sclerosis symptoms in selected patients

European research project to explore Alzheimer's diagnosis

World leaders call for action to reduce TB deaths among HIV-positive people

Nose stem cells used to treat Parkinson's

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News